Boublil and Schönberg’s LES MISÉRABLES has extended booking at the Sondheim Theatre in London until March 2026. Check out all ...

Bridgewater-based Cosette Pharmaceuticals announced Feb. 20 it entered into an agreement to acquire Mayne Pharma Group Ltd. in a $430 million deal. Mayne is an Australian-headquartered specialty ...

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to ...

With a $430 million buyout of Australia’s Mayne Pharma locked down, Cosette Pharmaceuticals is looking to become a leading force in women’s healthcare. The New Jersey-based drugmaker agreed to ...

BRIDGEWATER, N.J., February 20, 2025--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it ...

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised Cosette Pharmaceuticals, Inc (Cosette) on its pending A$672 million acquisition of Mayne Pharma Group Limited (Mayne) ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of ...

Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne ...

Mayne told shareholders that in the absence of a better offer, the board had unanimously agreed to a scheme of arrangement with ­Cosette at $7.40 a share cash, 37 per cent higher than Thursday ...

Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...

The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne Pharma and AstraZeneca buying the Chinese subsidiary of FibroGen.